These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27939616)

  • 21. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
    Richardson PG; Riches ML; Kernan NA; Brochstein JA; Mineishi S; Termuhlen AM; Arai S; Grupp SA; Guinan EC; Martin PL; Steinbach G; Krishnan A; Nemecek ER; Giralt S; Rodriguez T; Duerst R; Doyle J; Antin JH; Smith A; Lehmann L; Champlin R; Gillio A; Bajwa R; D'Agostino RB; Massaro J; Warren D; Miloslavsky M; Hume RL; Iacobelli M; Nejadnik B; Hannah AL; Soiffer RJ
    Blood; 2016 Mar; 127(13):1656-65. PubMed ID: 26825712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Thromboelastography in Pediatric Patients with Sinusoidal Obstructive Syndrome Receiving Defibrotide.
    Gendreau JL; Knoll C; Adams RH; Su LL
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):707-712. PubMed ID: 28115278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
    Corbacioglu S; Topaloglu O; Aggarwal S
    Clin Drug Investig; 2022 Jun; 42(6):465-476. PubMed ID: 35594010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Defibrotide therapy for patients with sinusoidal obstruction syndrome after hematopoietic stem cell transplantation].
    Yakushijin K; Okamura A; Ono K; Kawano Y; Kawano H; Funakoshi Y; Kawamori Y; Nishikawa S; Minagawa K; Sada A; Shimoyama M; Yamamoto K; Katayama Y; Matsui T
    Rinsho Ketsueki; 2009 Jan; 50(1):3-8. PubMed ID: 19225222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes.
    Coutsouvelis J; Avery S; Dooley M; Kirkpatrick C; Spencer A
    Support Care Cancer; 2018 Mar; 26(3):947-955. PubMed ID: 29022099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
    Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial.
    Grupp SA; Corbacioglu S; Kang HJ; Teshima T; Khaw SL; Locatelli F; Maertens J; Stelljes M; Stepensky P; Lopez P; Amber V; Pagliuca A; Richardson PG; Mohty M
    Lancet Haematol; 2023 May; 10(5):e333-e345. PubMed ID: 37001534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
    Ho VT; Revta C; Richardson PG
    Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of defibrotide in hepatic sinusoidal obstruction syndrome induced by hematopoietic stem cell transplantation].
    Liu ZL; Wang Y; Liu YL; Zhang J
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):92-96. PubMed ID: 33541030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Yang L; Qi J; Pan T; You T; Ruan C; Han Y
    Semin Thromb Hemost; 2019 Nov; 45(8):767-777. PubMed ID: 31627217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of sinusoidal obstruction syndrome with defibrotide: a single-center experience.
    Sucak GT; Aki ZS; Yagcí M; Yegin ZA; Ozkurt ZN; Haznedar R
    Transplant Proc; 2007 Jun; 39(5):1558-63. PubMed ID: 17580188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Pre-emptive strike"-the case for early treatment of hepatic sinusoidal obstruction syndrome with defibrotide.
    Rajagopal R; Phillips MB; Gottardo NG
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27036. PubMed ID: 29537138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOS for veno-occlusive disease: defibrotide prophylaxis.
    Platzbecker U; Bornhäuser M
    Lancet; 2012 Apr; 379(9823):1277-8. PubMed ID: 22364686
    [No Abstract]   [Full Text] [Related]  

  • 34. A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting.
    Tappe W; Aggarwal S; Topaloglu O; Iacobelli M
    Clin Appl Thromb Hemost; 2020; 26():1076029620935202. PubMed ID: 32687402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.
    Richardson PG; Smith AR; Kernan NA; Lehmann L; Ryan RJ; Grupp SA
    Transplant Cell Ther; 2021 Jan; 27(1):88.e1-88.e6. PubMed ID: 32950693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
    Kernan NA; Grupp S; Smith AR; Arai S; Triplett B; Antin JH; Lehmann L; Shore T; Ho VT; Bunin N; Iacobelli M; Liang W; Hume R; Tappe W; Soiffer R; Richardson P
    Br J Haematol; 2018 Jun; 181(6):816-827. PubMed ID: 29767845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research.
    Strouse C; Richardson P; Prentice G; Korman S; Hume R; Nejadnik B; Horowitz MM; Saber W
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1306-1312. PubMed ID: 27108694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
    Qureshi A; Marshall L; Lancaster D
    Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.
    Richardson PG; Soiffer RJ; Antin JH; Uno H; Jin Z; Kurtzberg J; Martin PL; Steinbach G; Murray KF; Vogelsang GB; Chen AR; Krishnan A; Kernan NA; Avigan DE; Spitzer TR; Shulman HM; Di Salvo DN; Revta C; Warren D; Momtaz P; Bradwin G; Wei LJ; Iacobelli M; McDonald GB; Guinan EC
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):1005-17. PubMed ID: 20167278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Sinusoidal Obstruction Syndrome With Defibrotide in Pediatric Cancer Patients Following Nontransplant-associated Chemotherapy: A Case Report and Review of the Literature.
    Lawrence MR; Bassal M; Ramphal R; Johnston DL
    J Pediatr Hematol Oncol; 2022 Apr; 44(3):e788-e791. PubMed ID: 33902061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.